Esperion Therapeutics | ESPR - Eigenkapital Und Reserven

Aktienkurs
2.59
Täglich Wechseln
0.04 1.37%
Monatlich
-22.60%
Jährlich
52.96%
Q1 Prognose
2.47




Eigenkapital Und Reserven Veränderung Datum
AbbVie USD -3.27B 628M 2025-12
Alnylam Pharmaceuticals USD 789.18M 555.28M 2025-12
Alterity Therapeutics Limited AUD 22.81M 5.29M 2023-06
Amarin USD 459.28M 387K 2025-12
Amgen USD 8.66B 961M 2025-12
Biogen USD 18.21B 573.5M 2025-09
BioMarin Pharmaceutical USD 6.09B 30.29M 2025-12
Cipla INR 329.19B 16.3B 2025-09
CSL USD 18.66B 2.75B 2025-12
Cytokinetics USD -659.62M 138.5M 2025-12
Daiichi Sankyo JPY 1.71T 57.86B 2025-12
Eli Lilly USD 26.54B 2.74B 2025-12
Esperion Therapeutics USD -301.96M 149.4M 2025-12
Geron USD 225.87M 22.83M 2025-12
Grifols EUR 6.21B 133.12M 2025-12
Halozyme Therapeutics USD 48.81M 455.1M 2025-12
Heron Therapeutics USD 13.28M 1.6M 2025-12
Ionis Pharmaceuticals USD 617.97M 13.76M 2025-09
Merck USD 51.85B 2.79B 2025-09
Minerva Neurosciences USD -140.75M 106.17M 2025-12
Moderna USD 8.65B 680M 2025-12
Nektar Therapeutics USD 85.09M 109.3M 2025-09
Pfizer USD 92.8B 4.11B 2025-09
PTC Therapeutics USD -205.31M 49.56M 2025-12
Puma Biotechnology USD 115.27M 10.55M 2025-09
Regeneron Pharmaceuticals USD 31.26B 299.1M 2025-12
Sanofi EUR 71.71B 1.55B 2025-12
Sarepta Therapeutics USD 1.14B 179.5M 2025-12
United Therapeutics USD 7.1B 506M 2025-12
Vanda Pharmaceuticals USD 327.19M 138.81M 2025-12